Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study;Erratum: Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: A retrospective multicenter study [Ann Oncol, 25, (2015) 611-618] DOI: 10.1093/annonc/mdt556

Annals of Oncology

Volumn 26, Issue 7, 2015, Pages 1518-

  Dieci, M V ^a,b,c   Criscitiello, C ^d   Goubar, A ^a   Viale, G ^d,e   Conte, P ^b,c   Guarneri, V ^b,c   Ficarra, G ^f   C Mathieu, M ^a   Delaloge, S ^a   Curigliano, G ^d   Andre, F ^a,g  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Breast cancer; Triple negative; Tumor lymphocytes; Neoadjuvant chemotherapy

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 84946706107     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt556     Document Type: Article

References (0)